Quality of care in diabetes: Understanding the guidelines

被引：9

作者：

Bouldin, MJ ^{[1
]}

Low, AK ^{[1
]}

Blackston, JW ^{[1
]}

Duddleston, DN ^{[1
]}

Holman, HE ^{[1
]}

Hicks, GS ^{[1
]}

Brown, CA ^{[1
]}

机构：

[1] Univ Mississippi, Med Ctr, Div Gen Internal Med, Dept Med, Jackson, MS 39216 USA

来源：

AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 2002年 / 324卷 / 04期

关键词：

diabetes; guidelines; quality indicators; review;

D O I：

10.1097/00000441-200210000-00006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We are in the midst of a global pandemic of diabetes. Despite the increasing burden of the disease, measurements of quality repeatedly show poor adherence to or implementation of current guidelines for diabetes care. This article will provide a brief review of the most significant randomized controlled clinical trials relevant to the current guidelines and then discuss essential treatment goals and the evidence that supports them. Several practical clinical questions related to the implementation of modern diabetes guidelines will be raised and answered. Finally, reasons for the poor quality performance observed will be examined.

引用

页码：196 / 206

页数：11

共 60 条

[51] PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA [J].

SHEPHERD, J ;

COBBE, SM ;

FORD, I ;

ISLES, CG ;

LORIMER, AR ;

MACFARLANE, PW ;

MCKILLOP, JH ;

PACKARD, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1301-1307

[52] COMPARISON OF QUANTITATIVE SENSORY-THRESHOLD MEASURES FOR THEIR ASSOCIATION WITH FOOT ULCERATION IN DIABETIC-PATIENTS [J].

SOSENKO, JM ;

KATO, M ;

SOTO, R ;

BILD, DE .

DIABETES CARE, 1990, 13 (10) :1057-1061

[53]

Stearne MR, 1998, BRIT MED J, V317, P713

[54]

Stearne MR, 1998, BMJ-BRIT MED J, V317, P703

[55] Factors associated with implementation of preventive care measures in patients with diabetes mellitus [J].

Streja, DA ;

Rabkin, SW .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (03) :294-302

[56]

THOMPSON TG, 2001, COMMUNICATION 0808

[57] Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) [J].

Turner, RC ;

Holman, RR ;

Stratton, IM ;

Cull, CA ;

Matthews, DR ;

Manley, SE ;

Frighi, V ;

Wright, D ;

Neil, A ;

Kohner, E ;

McElroy, H ;

Fox, C ;

Hadden, D .

LANCET, 1998, 352 (9131) :854-865

[58] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].

Turner, RC ;

Holman, RR ;

Cull, CA ;

Stratton, IM ;

Matthews, DR ;

Frighi, V ;

Manley, SE ;

Neil, A ;

McElroy, K ;

Wright, D ;

Kohner, E ;

Fox, C ;

Hadden, D ;

Mehta, Z ;

Smith, A ;

Nugent, Z ;

Peto, R ;

Adlel, AI ;

Mann, JI ;

Bassett, PA ;

Oakes, SF ;

Dornan, TL ;

Aldington, S ;

Lipinski, H ;

Collum, R ;

Harrison, K ;

MacIntyre, C ;

Skinner, S ;

Mortemore, A ;

Nelson, D ;

Cockley, S ;

Levien, S ;

Bodsworth, L ;

Willox, R ;

Biggs, T ;

Dove, S ;

Beattie, E ;

Gradwell, M ;

Staples, S ;

Lam, R ;

Taylor, F ;

Leung, L ;

Carter, RD ;

Brownlee, SM ;

Fisher, KE ;

Islam, K ;

Jelfs, R ;

Williams, PA ;

Williams, FA ;

Sutton, PJ .

LANCET, 1998, 352 (9131) :837-853

[59] Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus - Putting evidence into practice [J].

Vijan, S ;

Stevens, DL ;

Herman, WH ;

Funnell, MM ;

Standiford, CJ .

JOURNAL OF GENERAL INTERNAL MEDICINE, 1997, 12 (09) :567-580

[60]

1995, DIABETES CARE, V18, P141

← 1 2 3 4 5 6 →